Acetaminophen And Codeine Phosphate
Acetaminophen; Codeine Phosphate
Sourced from the FDA Orange Book
Key dates
Key dates
Approval
FDA approval date of this drug product.
May 31, 2001
25 yr 6 mo ago
Today
Pharmaceutical detail
Pharmaceutical detail
Active ingredient
ACETAMINOPHEN; CODEINE PHOSPHATE
Strength
300MG;60MG
Dosage form
TABLET
Route
ORAL
TE code
AA
Application
ANDA 040419
Product number
003
Marketing status
Prescription
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Other strengths in ANDA 040419
Active-ingredient family
Generic (ANDA) of Acetaminophen; Codeine Phosphate
- 2019Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 212418 · Elite Labs Inc
- 2019Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 211610 · Hibrow Hlthcare
- 2013Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 202800 · Aurolife Pharma LLC
- 2011Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 091238 · Chartwell Molecular
- 2008Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 040779 · Amneal Pharms Ny
- 2002Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 040452 · Able
- 2002Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 040459 · Able
- 1997Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 040223 · Duramed Pharms Barr
- 1996Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 040098 · Dava Pharms Inc
- 1996Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 040119 · Pai Holdings
- 1994Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 089997 · Chartwell
- 1994Acetaminophen And Codeine PhosphateGeneric (ANDA)
ANDA 089998 · Chartwell
Listed patents
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Acetaminophen And Codeine Phosphate — frequently asked questions
Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.
Built directly from the FDA Orange Book data file. This product page links back to the Acetaminophen; Codeine Phosphate active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

